iShares Biotechnology ETF IBB
218.14 USD +0.96 (+0.44%)
At closeNov 12, 2026, 4:01 AM EST
218.01 -0.13 -0.06%
Pre-market · Nov 12, 4:01 AM ET
215.87 Day range 218.77
159.68 52-week range 222.29
- YTD
- +29.25%
- 1 year
- +32.90%
News
benzinga.com Hims-Eli Lilly GLP-1 Deal Meets Summit’s FDA Gamble: Which Biotech ETFs Stand to Gain? Biotech ETFs face key FDA catalysts as Summit Therapeutics' decision and the Hims-Lilly GLP-1 deal put XLV, IBB and XBI in focus.
fool.com Choosing Healthcare ETFs: Why IHE Outperforms IBB for Many Investors The iShares U.S. Pharmaceuticals ETF offers a lower expense ratio and a significantly higher dividend yield than the iShares Biotechnology ETF. The iShares Biotechnology ETF provides exposure to a…
benzinga.com Alphabet Posts Worst Week Since 2011, Intel Suffers Record Crash as Warsh Sees 'Cracks': This Week on Wall Street Alphabet logs its worst week since 2011 and Intel its worst day ever as the AI trade cracks, while health care posts a record month against the market.
benzinga.com Dow Jones Climbs to 52,000 While Chips Bleed on Rate-Hike Fears: Stock Market Today Hot inflation data fuels Fed rate-hike bets, hammering chip and AI-hardware stocks while the Dow tops 52,000 and small caps hold gains; gold rebounds.
benzinga.com Nasdaq 100 Drops 1% on Hot CPI, SOXX Falls 7th Day: Stock Market Today The Nasdaq 100 fell 1% by midday Wednesday after September CPI topped forecasts, pushing Treasury yields and rate-hike bets higher.